Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7911

1.

Drug-induced liver injury: a safety review.

García-Cortés M, Ortega-Alonso A, Lucena MI, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).l.

Expert Opin Drug Saf. 2018 Aug;17(8):795-804. doi: 10.1080/14740338.2018.1505861. Review.

PMID:
30059261
2.

Autoimmune hepatitis following influenza virus vaccination: Two case reports.

Sasaki T, Suzuki Y, Ishida K, Kakisaka K, Abe H, Sugai T, Takikawa Y.

Medicine (Baltimore). 2018 Jul;97(30):e11621. doi: 10.1097/MD.0000000000011621.

3.

In-silico approach for drug induced liver injury prediction: Recent advances.

Saini N, Bakshi S, Sharma S.

Toxicol Lett. 2018 Oct 1;295:288-295. doi: 10.1016/j.toxlet.2018.06.1216. Epub 2018 Jul 5. Review.

PMID:
29981923
4.

Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.

Rizvi S, Gawrieh S.

Drugs Aging. 2018 Jul;35(7):589-602. doi: 10.1007/s40266-018-0556-0. Review.

PMID:
29971609
5.

Hepatitis E - A new era in understanding.

Krzowska-Firych JM, Lucas C, Lucas G, Tomasiewicz K.

Ann Agric Environ Med. 2018 Jun 20;25(2):250-254. doi: 10.26444/aaem/75142. Epub 2017 Jul 17. Review.

6.

Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.

Ling C, Gavin M, Hanson J, McCarthy DM.

Dig Dis Sci. 2018 Jul;63(7):1751-1755. doi: 10.1007/s10620-018-5135-z. No abstract available.

PMID:
29934698
7.

Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?

Kaushik N, Anang S, Ganti KP, Surjit M.

DNA Cell Biol. 2018 Jul;37(7):593-599. doi: 10.1089/dna.2018.4175. Epub 2018 Jun 13. Review.

PMID:
29897788
8.

Predicting drug-induced cholestasis: preclinical models.

Petrov PD, Fernández-Murga ML, López-Riera M, Goméz-Lechón MJ, Castell JV, Jover R.

Expert Opin Drug Metab Toxicol. 2018 Jul;14(7):721-738. doi: 10.1080/17425255.2018.1487399. Epub 2018 Jun 20. Review.

PMID:
29888962
9.

Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver.

Hedrington MS, Davis SN.

Expert Opin Drug Metab Toxicol. 2018 Jul;14(7):671-677. doi: 10.1080/17425255.2018.1483337. Epub 2018 Jun 7. Review.

PMID:
29847748
10.

Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.

Louvet A, Thursz MR, Kim DJ, Labreuche J, Atkinson SR, Sidhu SS, O'Grady JG, Akriviadis E, Sinakos E, Carithers RL Jr, Ramond MJ, Maddrey WC, Morgan TR, Duhamel A, Mathurin P.

Gastroenterology. 2018 Aug;155(2):458-468.e8. doi: 10.1053/j.gastro.2018.05.011. Epub 2018 May 5.

PMID:
29738698
11.

Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options.

Teschke R.

Expert Opin Pharmacother. 2018 Jun;19(8):779-793. doi: 10.1080/14656566.2018.1465929. Epub 2018 Apr 30. Review.

PMID:
29708448
12.

Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective.

Karamchandani DM, Chetty R.

J Clin Pathol. 2018 Aug;71(8):665-671. doi: 10.1136/jclinpath-2018-205143. Epub 2018 Apr 27. Review.

PMID:
29703758
13.

Effect of Stains on LDL Reduction and Liver Safety: A Systematic Review and Meta-Analysis.

Liang X, He Q, Zhao Q.

Biomed Res Int. 2018 Mar 5;2018:7092414. doi: 10.1155/2018/7092414. eCollection 2018. Review.

14.

Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.

Czaja AJ.

Dig Dis Sci. 2018 Jul;63(7):1706-1725. doi: 10.1007/s10620-018-5072-x. Epub 2018 Apr 18. Review.

PMID:
29671161
15.

Dissecting the molecular pathophysiology of drug-induced liver injury.

Ye H, Nelson LJ, Gómez Del Moral M, Martínez-Naves E, Cubero FJ.

World J Gastroenterol. 2018 Apr 7;24(13):1373-1385. doi: 10.3748/wjg.v24.i13.1373. Review.

16.

Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

Hytiroglou P, Theise ND.

Virchows Arch. 2018 Jul;473(1):15-22. doi: 10.1007/s00428-018-2340-2. Epub 2018 Mar 27. Review.

PMID:
29589101
17.

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.

Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagström H, Purnak T, Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-Loza AJ, Berg T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S.

Dig Dis Sci. 2018 May;63(5):1348-1354. doi: 10.1007/s10620-018-5011-x. Epub 2018 Mar 22.

PMID:
29569003
18.

Intestinal microbiome and permeability in patients with autoimmune hepatitis.

Cai W, Ran Y, Li Y, Wang B, Zhou L.

Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):669-673. doi: 10.1016/j.bpg.2017.09.013. Epub 2017 Sep 18. Review.

PMID:
29566910
19.

Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.

Kok B, Lester ELW, Lee WM, Hanje AJ, Stravitz RT, Girgis S, Patel V, Peck JR, Esber C, Karvellas CJ; United States Acute Liver Failure Study Group.

Dig Dis Sci. 2018 Jun;63(6):1654-1666. doi: 10.1007/s10620-018-5023-6. Epub 2018 Mar 21. Review.

PMID:
29564668
20.

Fitz-Hugh-Curtis syndrome associated with tuberculous salpingitis and peritonitis: a case presentation and review of literature.

Coremans L, de Clerck F.

BMC Gastroenterol. 2018 Mar 20;18(1):42. doi: 10.1186/s12876-018-0768-0. Review.

Supplemental Content

Loading ...
Support Center